Unveiling the molecular basis of inflamm-aging induced by advanced glycation end products (AGEs)-modified human serum albumin (AGE-HSA) in patients with different immune-mediated diseases

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 252(2023) vom: 15. Juli, Seite 109655
Auteur principal: Shen, Chieh-Yu (Auteur)
Autres auteurs: Li, Ko-Jen, Wu, Cheng-Han, Lu, Cheng-Hsun, Kuo, Yu-Min, Hsieh, Song-Chou, Yu, Chia-Li
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't AGE-modified human serum albumin Immune-mediated diseases Inflamm-aging N(e)-carboxyethyl-lysine N(e)-carboxymethyl-lysine Senescence-associated β-galactosidase advanced glycation end products-human serum albumin Serum Albumin plus... Interleukin-2 Glycation End Products, Advanced Serum Albumin, Human ZIF514RVZR